Incidence trends and mortality rates of gastric cancer in Israel
Tóm tắt
Gastric cancer is the fourth most common malignancy worldwide. The incidence trends and mortality rates of gastric cancer in Israel have not been studied in depth. The aim of our study was to try and investigate the aforementioned issues in Israel in different ethnic groups. This retrospective study is based on the data of The Israel National Cancer Registry and The Central Bureau of Statistics. Published data from these two institutes were collected, summarized, and analyzed in this study. Around 650 new cases of gastric cancer are diagnosed yearly in Israel. While we noticed a decline during the period 1990–2007 in the incidence in the Jewish population (13.6–8.9 and 6.75–5.42 cases per 100,000 in Jewish men and women, respectively), an increase in the Arab population was noticed (7.7–10.2 and 3.7–4.2 cases per 100,000 in men and women, respectively). Age-adjusted mortality rates per 10,000 cases of gastric cancer decreased significantly, from 7.21 in 1990 to 5.46 in 2007, in the total population. The 5-year relative survival showed a slight increase for both men and women. There is a difference in the incidence and outcome of gastric cancer between the Jewish and Arab populations in Israel. The grim prognosis of gastric cancer patients in Israel is probably due to the advanced stage at which gastric cancer is diagnosed in Israel.
Tài liệu tham khảo
Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group study 9501. J Clin Oncol. 2004;22:2767–73.
Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol. 2004;22:2069–2077.
Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19:1893–907.
Verdecchia A, Corazziari I, Gatta G, Lisi D, Faivre J, Forman D, et al. Explaining gastric cancer survival differences among European countries. Int J Cancer. 2004;109:737–41.
Schlansky B, Sonnenberg A. Explaining gastric cancer survival differences among European countries. Am J Gastroenterol. 2011;106:1978–85.
Imamura Y, Yoshimi I. Comparison of cancer mortality (stomach cancer) in five countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960–2000). Jpn J Clin Oncol. 2005;35:103–5.
Deans C, Yeo MS, Soe MY, Shabbir A, Ti TK, So JB. Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome. World J Surg. 2011;35:617–24.
Jézéquel J, Bessaguet C, Verveur C, Faycal J, Richert Z, Metges JP, et al. Trends in incidence, management, and survival of gastric and cardia carcinomas in the area of Finistere (France) between 1984 and 2003. Eur J Gastroenterol Hepatol. 2010;22:1412–9.
Rozen P, Liphshitz I, Barchana M. The changing epidemiology of upper gastrointestinal cancers in Israel: clinical and screening implications. Eur J Cancer Prev. 2009;18:191–8.
Engel LS, Chow WH, Vaughan TL. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404–13.
Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50.
Buffart TE, Louw M, van Grieken NC, Tijssen M, Carvalho B, Ylstra B, et al. Gastric cancers of Western European and African patients show different patterns of genomic instability. BMC Med Genomics. 2011;4:7.
Sugai T, Habano W, Uesugi N, Jao YF, Nakamura S, Abe K, et al. Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers: a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas. Mod Pathol. 2004;17:1223–34.
Dreznik A, Purim O, Idelevich E, Kundel Y, Sulkes J, Sulkes A, et al. Gastric cancer: biology and clinical manifestations in Israel. J Surg Oncol. 2011;105:316–22. doi:10.1002/jso.22078.
Jung KW, Park S, Kong HJ, Won YJ, Boo YK, Shin HR, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006–2007. J Korean Med Sci. 2010;25:1113–21.
Keinan-Boker L, Noyman N, Chinich A, Green MS, Nitzan-Kaluski D. Overweight and obesity prevalence in Israel: findings of the first national health and nutrition survey (MABAT). Isr Med Assoc J. 2005;7:219–23.
Zidan J, Sikorsky N, Basher W, Sharabi A, Friedman E, Steiner M. Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel. Int J Cancer 2011. doi:10.1002/ijc.26431.
Ghaffari SR, Rafati M, Sabokbar T, Dastan J. A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer. Eur J Surg Oncol. 2010;36:559–62.
Marie MA, Altahir IE. Relationship between the extent of DNA damage and gastritis in normal and Helicobacter pylori-infected patients. Gut Liver. 2011;5:315–20.
Gilboa S, Gabay G, Zamir D, Zeev A, Novis B. Helicobacter pylori infection in rural settlements (Kibbutzim) in Israel. Int J Epidemiol. 1995;24:232–7.
Rabin I, Chikman B, Lavy R, Poluksht N, Halpern Z, Wassermann I, et al. The accuracy of sentinel node mapping according to T stage in patients with gastric cancer. Gastric Cancer. 2010;13:30–5.
Strong VE, Song KY, Park CH, Jacks LM, Gonen M, Shah M, et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg. 2010;251:640–6.
Shin A, Kim J, Park S. Gastric cancer epidemiology in Korea. J Gastric Cancer. 2011;11:135–40.